Abstract: This invention pertains to a curable composition comprising a first component having beta-ketoacetate and/or malonate functionalities and a second component having two or more aldehyde functionalities. The compositions can be cured at room temperature or low temperatures to yield crosslinked networks that are capable of providing desirable properties for coating and adhesive applications. The reactive functionalities of beta-ketoacetate, malonate, and aldehyde can be either on polymers as the main binders or on small molecules as the crosslinkers. The curable compositions desirably are either solventless or organic solvent based.

Abstract: The present invention relates in particular to a mixture comprising or at least essentially consisting of compound of formula (Ia) and (beta,beta-(4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole) of the formula (Ib), wherein the weight ratio of the compound of the formula (Ia) to the compound of the formula (Ib) in the mixture is in the range from 90:10 to 99:1. The present invention further relates to a method for producing such a mixture, to new odorant and/or aroma substance compositions, and to the use of a mixture of the invention (a) for masking or diminishing the one or more unpleasant olfactory impressions of one or more unpleasantly smelling substances, and/or (b) for intensifying the one or more pleasant olfactory impressions of one or more pleasantly smelling substances.

Abstract: A fragrance composition is described which comprises at least two different fragrance accords, wherein at least 30 wt % of each fragrance accord comprises the key contributor(s) of said fragrance accord and wherein the average of the odor detection thresholds of said key contributor(s) for each fragrance accord is within the same order of magnitude as the average of the odor detection thresholds of the key contributor(s) for said other fragrance accord(s), and wherein the base note(s) of each fragrance accord comprises less than 15% of the notes of said accord. Methods of manufacture thereof, together with methods of attenuating fragrance habituation, are also described.

Abstract: The disclosure relates to special orthoformic acid esters of formula (I), as defined herein, which can be used as thermally labile and acid-labile fragrance storage substances. The disclosure further relates to detergents and cleaning agents, cosmetic agents and air freshening products containing such orthoformic acid esters, as well as to a method for lastingly fragrancing surfaces.

Abstract: A fragrance composition is described which comprises: at least two different fragrance accords wherein at least 30 wt % of each fragrance accord comprises the key contributor(s) of said fragrance accord and wherein the average of the odor detection thresholds of said key contributor(s) for each fragrance accord is within the same order of magnitude as the average of the odor detection thresholds of the key contributor(s) for said other fragrance accord(s); and wherein the base note(s) of each fragrance accord comprises less than 15% of the notes of said accord. Methods of manufacture thereof together with methods of attenuating fragrance habituation are also described.

Abstract: The present disclosure provides a composition comprising a multi-domain peptide capable of self-assembly into a nanofibrous hydrogel structure capable of stimulating a robust angiogenic response. In one embodiment, the composition comprises a short 15 amino acid VEGF-165 peptide mimic conjugated to a 16 amino acid multidomain peptide. A method for promoting angiogenesis and/or treating ischemic wounds in a subject is also provided.

Abstract: The present invention relates to compounds of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein R1 represents a substituent of the benzene ring and is a bromine atom or a linear, branched or cyclic C1-8 alkyl, alkenyl, alkoxy or alkenyloxy group; R2 represents a C1-3 alkyl group; and R3 represents a hydrogen atom or a methyl or ethyl group; and their use as perfuming ingredients, for instance to impart odor notes of the watery/ozone type.

Abstract: The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities' options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.

Abstract: A process of forming methoxymelonal comprising the steps of treating a solution of citronellene to ozonolysis, and hydrogenating the product formed to provide methoxymelonal.

Abstract: A fragrance composition and use thereof by inhalation to promote activated, pleasant moods. The fragrance composition comprises at least 75% by weight of perfume materials including at least 10% by weight of at least three specific materials from a group identified as Group IMP and optionally up to 90% of specific materials selected from groups identified as HMR, HMI, HMP, RMP and GEN, the amounts of materials from said Groups falling within specified relationships.

Abstract: A compound of the formula I in which R1 is H or methyl, R2 is H, methyl or ethyl, R3 and R4 are independently hydrogen, methyl, ethyl, n-propyl or iso-propyl, and the dashed lines representing the alternative possibilities of there being present either an additional double bond or an additional group R5, which is H or methyl. The compounds possess a marine odor with sweet character, and are useful in fine and functional fragrances.

Abstract: The present invention relates to novel 1,3-oxathiane compounds represented by Formula I: wherein R is selected from the group consisting of ethyl, butyl, propyl, and (methylthio)ethyl, and their uses to enhance a flavor or fragrance composition.

Abstract: The present invention relates to compounds of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein R1 represents a substituent of the benzene ring and is a bromine atom or a linear, branched or cyclic C1-8 alkyl, alkenyl, alkoxy or alkenyloxy group; R2 represents a C1-3 alkyl group; and R3 represents a hydrogen atom or a methyl or ethyl group; and their use as perfuming ingredients, for instance to impart odor notes of the watery/ozone type.

Abstract: A fragrance mixture, preferably perfume oil, is described, comprising the constituents (a) (cyclopent-2-enyl ethyl acetate) and additionally (b) one or a plurality of fragrances, preferably with a floral odor note, from the group consisting of alcohols and aldehydes with a molecular weight of 210 g/mol or less and/or (c) one or a plurality of fragrances from the group consisting of ketones, ethers and esters with a molecular weight in the range from 190 g/mol through 250 g/mol.

Abstract: The present invention primarily relates to fragrance substance mixtures, preferably perfume oils, comprising (a) compound (A-1) and compound (A-2) and (b) one or more further musk fragrance substances, which are not isolongifolenyl methyl ethers, wherein the mass ratio of the total quantity of musk fragrance substances of constituent (b) to the total quantity of compounds (A-1) and (A-2) (constituent (a)) is preferably greater than or equal to 1:2. Furthermore, the present invention relates to perfumed products containing fragrance substance mixtures of this type according to the invention, in particular perfume oils, and a method for modifying certain olfactory properties of fragrance substances, fragrance substance mixtures, perfume oils or correspondingly perfumed products.

Abstract: The present invention relates to novel compounds and their use in fragrance compositions. Novel 3.2.

Abstract: The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities' options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.

Abstract: The present invention primarily relates to the use of dioxolanes of the following Formula (I) as fragrance and/or flavoring substances, certain perfume and/or flavoring compositions comprising these dioxolanes and corresponding perfumed and/or flavored items. The present invention also relates to a method for producing the dioxolanes of Formula (I) and certain new dioxolanes according to Formula (I).

Abstract: A compound of the formula I n which R1 is H or methyl, R2 is H, methyl or ethyl, R3 and R4 are independently hydrogen, methyl, ethyl, n-propyl or iso-propyl, and the dashed lines representing the alternative possibilities of there being present either an additional double bond or an additional group R5, which is H or methyl. The compounds possess a marine odour with sweet character, and are useful in fine and functional fragrances.

Abstract: The present invention relates to novel 1,3-oxathiane compounds represented by Formula I: wherein R is selected from the group consisting of ethyl, butyl, propyl, and (methylthio)ethyl, and their uses to enhance a flavor or fragrance composition.

Abstract: The present invention relates primarily to the novel compound of the formula (II) and certain mixtures comprising the compound of the formula (II) and use thereof as perfume. In addition the invention relates to perfume mixtures and perfumed products comprising a (preferably sensorially effective) amount of the compound of the formula (II) or a mixture according to the invention.

Abstract: Acetal derivatives of 2,2,3,6-tetramethyl-1-cyclohexane/ene-carbaldehyde of formula (I): for use in the perfumery industry as well as the resulting compositions or articles containing one or more of these compounds. In formula (I), one dotted line indicates the presence of a carbon-carbon single or double bond and the other dotted line indicates the presence of a carbon-carbon single bond, R1 represents a hydrogen atom or a methyl or ethyl group; and each R, taken alone, simultaneously or independently, represents a C1-3 alkyl or alkenyl group, or the R groups, taken together, represent a C2-6 hydrocarbon group optionally including an oxygen atom.

Abstract: The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities' options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.

Abstract: Disclosed herein is a fragrant formulation comprising a fragrant composition, and an alkyl ketal ester. Disclosed herein too are methods for manufacturing the fragrant formulation.

Abstract: The invention features a polypeptide complex synthesized by bacteria of the genus Clostridia that contains the serotype E botulinum neurotoxin and five neurotoxin associated polypeptides having molecular weights of about 118, 80, 65, 40, and 18 kDa, respectively. The complex is useful in the treatment of diseases or conditions that are caused by excessive release of acetylcholine from presynaptic nerve terminals.

Abstract: The present disclosure refers to 5,7-dioxatetracyclo[9.2.1.01.9,04.8]tetradecane derivatives of formula I wherein R1-R3 have the same meaning as given in the description. The disclosure furthermore refers to their preparation and to perfume compositions and fragrance applications including them.

Abstract: The invention relates to the use of n-hexadecyl n-nonanoate (CAS number 72934-15-7, hereafter cetyl nonanoate) and n-octadecyl n-nonanoate (CAS number 107647-13-2, hereafter stearyl nonanoate) and to the mixtures thereof (CAS number 878027-13-5) as fixatives for fragrance substances. The invention also relates to specific compositions comprising (A) cetyl nonanoate and/or stearyl nonanoate as well as (B) one or more fragrance substances. The invention also relates to a process for the preparation of such compositions as well as to (cosmetic) products comprising a composition according to the invention. The invention further relates to a process for imparting, intensifying or modifying an odor on (human) skin. A particular aspect of the present invention relates to the improvement in the adhesive strength of a composition according to the invention on (human) skin and/or (human) hair.

Abstract: The present invention provides compounds for targeting endothelial cells, tumor cells or other cells that express the NP-1 receptor, compositions containing the same and methods for their use. Additionally, the present invention includes diagnostic, therapeutic and radiotherapeutic compositions useful for visualization, therapy or radiotherapy.

Abstract: Ligands of CCX-CKR2 and the biological role of CCX-CKR2 in cancer is described.

Abstract: Aqueous fragrance emulsions are prepared from a hydrophobic fragrance substance, a cyclodextrin derivative, and a polysorbate. The emulsions are stable despite containing a high proportion of fragrance and can be used to prepare uniform coatings on substrates.

Abstract: The present invention a method of improving, enhancing, or modifying a fragrance formulation through the addition of an olfactory acceptable amount of the following compound: wherein R represents a saturated C2-C4 alkyl straight chain or branched.

Abstract: A novel compound 4H-indeno[1,2-D]-1,3-dioxole, 3a,3b,5,6,7,8a-hexahydro-2,2,3a,3b,7,7-hexamethyl 1 is disclosed as well as the use of the compound as a fragrance chemical. The fragrance compound is suitable for use in creating fragrances, and scents in items such as perfumes, colognes and personal care products.

Abstract: The present invention relates to novel 1,3-oxathiane compounds represented by Formula I: wherein R is selected from the group consisting of ethyl, butyl, propyl, and (methylthio)ethyl, and their uses to enhance a flavor or fragrance composition.

Abstract: The present invention provides perfume compositions that control the perception of tactile attributes of consumer products that contain the inventive compositions and/or the surfaces of articles treated therewith.

Abstract: The present invention relates to a pharmaceutical composition comprising (a) a polynucleotide comprising or consisting of a nucleotide sequence encoding a polypeptide with the amino acid sequence as set forth in SEQ ID NO: 2; (b) a polynucleotide comprising or consisting of a nucleotide sequence which is a fragment of a nucleotide sequence encoding the polypeptide with the amino acid sequence as set forth in SEQ ID NO: 2, wherein the polypeptide encoded by said polynucleotide has arteriogenic activity; (c) a polynucleotide comprising or consisting of a nucleotide sequence encoding a polypeptide, wherein said polypeptide exhibits at least 70% sequence identity with the sequence of the polypeptide encoded by the polynucleotide of (a) or (b) over the entire length, and wherein said polypeptide has arteriogenic activity; and/or (d) a polypeptide encoded by the polynucleotide of any one of (a) to (c).

Abstract: The present invention relates to 2-(3-methylbutyl)-4-propyl-1,3-oxathiane and its use as perfuming ingredients. The present invention also concerns the use of this compound in the perfumery industry as well as the compositions or articles containing this compound.

Abstract: A compound of the formula I in which the moieties R1-R13 are independently selected from the following moieties: R1, R5, R6, R8, R11—H, methyl, ethyl, propyl, isopropyl; R3—H, methyl, ethyl, propyl, isopropyl, vinyl; R4—H, methyl, ethyl; R2, R7, R9—H, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, t-butyl; R10—H, methyl, ethyl, propyl, isopropyl, t-butyl; R12, R13—H, C1-6 linear or branched alkyl; or R4 and R11 together with the carbon atoms to which they are attached form a 5- or a 6-membered cycloalkyl ring; or R6 and R7 together with the carbon atoms to which they are attached form a cycloalkyl ring having 3, 4, 5 or 6 members. The compounds have strong odours and are useful in fragrances and fragrance applications.

Abstract: A composition of microscopic devices utilizable in a medical diagnostic or therapeutic procedure. Each microscopic device includes a nanostructure provided with a ligand for effectively coupling the nanostructure to a predetermined chemical or molecular site. A medical method in part comprises inserting the medical devices into a patient, attaching the nanostructures via the respective ligands to instances of a predetermined type of target structure inside the patient, and thereafter activating the nanostructures to perform a preselected medical diagnostic or therapeutic function.

Abstract: The present invention relates to the use of cytokines of the TGF-?-superfamily as well as nucleic acids encoding said cytokines for the treatment and diagnosis of skin related disorders, including hair and gland related disorders in mammals.

Abstract: The invention relates to the ether lactone of formula (I) which is characterized by interesting and original odor characteristics, which diffuses extremely well and is suitable for use as a fragrance, for example in cosmetic preparations, technical products or in alcoholic perfumery.

Abstract: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides. The invention also relates to the treatment of diseases associated with reduced or increased levels of apoptosis using antibodies specific for DR4, which may be agonists and/or antagonists of DR4 activity.

Abstract: The use of 2-(1,1,4-trimethylpent-3-enyl)-4,7-dihydro-1,3-dioxepin as an agent for providing (a) hair or (b) textile fibres with a fresh smell is described.

Abstract: The use (i) of a compound of formula 2 wherein R3 and R4 independently of one another represent a C2-C4-alkyl or -alkenyl radical or (ii) of a mixture consisting of or comprising: at least one such compound of formula 2 as well as at least one compound of formula 1 and/or at least one compound of formula 3, wherein R1, R2, R3, R4, R5 and R6 independently of one another represent a C2-C4-alkyl or -alkenyl radical, as a fragrance or flavouring is described.

Abstract: Personal care products are provided. An exemplary personal care product includes a composition that is applied to the body or clothing, or an article applied against the body; a plurality of particles associated with the composition or a component of the article, the plurality of particles, at least some of the plurality of particles comprising a cyclodextrin complexing material and a first fragrance material, wherein the percent of the first fragrance material that is complexed with the cyclodextrin is greater than about 90%, so that the perceptibility of the first fragrance is minimized prior to its release; and a second fragrance material that is not complexed with the cyclodextrin and that is different from the first fragrance material, wherein the composition or article does not contain an antiperspirant active.

Abstract: Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention. Transgenic animals of the present invention are produced by introducing into developing embryos DNA that encodes Factor IX, such that the foreign DNA is stably incorporated in the DNA of germ line cells of the mature animal. Particularly efficient expression was accomplished using a chimeric construct comprising a mammary gland specific promoter, Factor IX cDNA that lacked the complete or any portion of the 5?-untranslated and 3?-untranslated region, which is substituted with a 5-? and 3?-end of the mouse whey acidic protein gene. In vitro cell cultures of cells explanted from the transgenic mammal of the invention and methods of producing Factor IX from such said culture and methods of treating hemophilia B are also described.

Abstract: A compound of the formula I in which the moieties R1—R13 are independently selected from the following moieties: R1, R5, R6, R8, R11—H, methyl, ethyl, propyl, isopropyl; R3—H, methyl, ethyl, propyl, isopropyl, vinyl; R4—H, methyl, ethyl; R2, R7, R9—H, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, t-butyl; R10—H, methyl, ethyl, propyl, isopropyl, t-butyl; R12, R13—H, C1-6 linear or branched alkyl; or R4 and R11 together with the carbon atoms to which they are attached form a 5- or a 6-membered cycloalkyl ring; or R6 and R7 together with the carbon atoms to which they are attached form a cycloalkyl ring having 3, 4, 5 or 6 members. The compounds have strong odours and are useful in fragrances and fragrance applications.

Abstract: Mixtures are described which comprise or consist of 3-(4-methylcyclohex-3-enyl)butyraldehyde (limonenal) and (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole (Ambrocenide®), the weight ratio of limonenal to Ambrocenide® being in the range from 150:1 to 2500:1.

Abstract: An acetal of formula I: is described in which the radicals R1 to R6 independently of one another are eac hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl, n=0 or 1, and there is a single bond or double bond at the location of a broken line between two C atoms, any double bond present in the chain linking the aliphatic ring to the acetal group having the E or Z configuration, with the proviso that the number of double bonds incorporating a C atom of the aliphatic ring is 0 or 1, and the number of double bonds not incorporating a C atom of the aliphatic ring is 0 or 1.

Abstract: The present invention is directed to a novel dioxin compound and the use of the novel compound in creating fragrances, and scents in items such as perfumes, colognes and personal care products.

Abstract: The invention relates to the field of masking mineral oil odor and the fragrancing of mineral oils. In this connection, the invention relates to a selection of particularly suitable odoriferous substances for masking a mineral oil odor and for fragrancing mineral oils. The invention furthermore relates to additives and to corresponding fragranced mineral oils themselves, in particular motor fuels and heating or lubricant oils.